FDA-cleared profile

Aplio i900/i800/i700 Diagnostic Ultrasound System, Software V7.0 (TUS-AI900, TUS-AI800, TUS-AI700)

Canon Medical Systems Corporation · Ultrasound · FDA-cleared (510(k))

Authorized purpose: Aplio i900/i800/i700 V7.0 is a mobile diagnostic ultrasound system with supported body and cardiac clinical applications and imaging modes for trained physicians and legally qualified users.

Clinical role
Supports diagnostic ultrasound acquisition and review across standard imaging modes. Auto Plane Detection selects candidate cardiac views; Quick Strain launches left-ventricular wall-motion tracking for three apical views; Auto LVOT and Auto AoV trace Doppler waveforms to reduce manual tracing time; right-ventricular and right-atrial wall-motion tracking are also added.
Images and patients
Ultrasound · Multi-region
Key limitation
Keep in mind: The cardiac automation features support rather than replace trained-user review. FDA-reported validation used previously acquired data from one U.S. clinical site, with 50 selected patients for Auto Plane Detection and Quick Strain and 45 for each Doppler-tracing evaluation; the summary does not report prospective clinical outcomes or multisite validation.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Aplio i900/i800/i700 V7.0 is a mobile diagnostic ultrasound system with supported body and cardiac clinical applications and imaging modes for trained physicians and legally qualified users.
  • Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Multi-region Input: Ultrasound images and Doppler waveforms acquired on compatible Aplio i900, i800, or i700 systems using supported linear, convex, and sector probes operating at approximately 2 to 33 MHz; the cardiac automation features use supported chamber views or LVOT and aortic-valve waveforms.
  • Who uses it?Intended users: Physicians or other legally qualified persons who have received appropriate training; the validation references clinical sonographers representative of intended U.S. users for the cardiac workflow features.
  • What does the software produce?Output: Diagnostic ultrasound images and measurements plus feature-specific candidate cardiac-view selection, wall-motion-tracking results including EDV, ESV, EF, and GLS, and automatically traced LVOT or aortic-valve Doppler measurements for qualified-user review.
  • What is its most important limitation?Key limitation: The cardiac automation features support rather than replace trained-user review. FDA-reported validation used previously acquired data from one U.S. clinical site, with 50 selected patients for Auto Plane Detection and Quick Strain and 45 for each Doppler-tracing evaluation; the summary does not report prospective clinical outcomes or multisite validation.

Clinical takeaway. Clinical role: Aplio i900/i800/i700 V7.0 is a mobile diagnostic ultrasound system with supported body and cardiac clinical applications and imaging modes for trained physicians and legally qualified users.

Evidence takeaway. Evidence from the reviewed source record: Manufacturer-sponsored validation used locked, sequestered test data from one U.S. clinical site and three licensed sonographers for truthing. The reported results establish feature-level agreement and workflow time reduction, not improved patient outcomes.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Aplio i900/i800/i700 V7.0 is a mobile diagnostic ultrasound system with supported body and cardiac clinical applications and imaging modes for trained physicians and legally qualified users.
  • Exact FDA submission
  • Checked 2026-09-04
Workflow role
Supports diagnostic ultrasound acquisition and review across standard imaging modes. Auto Plane Detection selects candidate cardiac views; Quick Strain launches left-ventricular wall-motion tracking for three apical views; Auto LVOT and Auto AoV trace Doppler waveforms to reduce manual tracing time; right-ventricular and right-atrial wall-motion tracking are also added.
  • Exact FDA submission
  • Checked 2026-09-04
Required input
Ultrasound images and Doppler waveforms acquired on compatible Aplio i900, i800, or i700 systems using supported linear, convex, and sector probes operating at approximately 2 to 33 MHz; the cardiac automation features use supported chamber views or LVOT and aortic-valve waveforms.
  • Exact FDA submission
  • Checked 2026-09-04
Output and clinician action
Diagnostic ultrasound images and measurements plus feature-specific candidate cardiac-view selection, wall-motion-tracking results including EDV, ESV, EF, and GLS, and automatically traced LVOT or aortic-valve Doppler measurements for qualified-user review.
  • Exact FDA submission
  • Checked 2026-09-04
Care setting
Hospitals, clinics, and other clinical ultrasound settings supported by the configured system and transducers.
  • Exact FDA submission
  • Checked 2026-09-04

Prior source-backed dossier value: Hospital and clinical environments performing diagnostic ultrasound, including cardiac ultrasound workflows.

Intended users
Physicians or other legally qualified persons who have received appropriate training; the validation references clinical sonographers representative of intended U.S. users for the cardiac workflow features.
  • Exact FDA submission
  • Checked 2026-09-04
Limitations
The cardiac automation features support rather than replace trained-user review. FDA-reported validation used previously acquired data from one U.S. clinical site, with 50 selected patients for Auto Plane Detection and Quick Strain and 45 for each Doppler-tracing evaluation; the summary does not report prospective clinical outcomes or multisite validation.
  • Exact FDA submission
  • Checked 2026-09-04
Evidence summary
Manufacturer-sponsored validation used locked, sequestered test data from one U.S. clinical site and three licensed sonographers for truthing. The reported results establish feature-level agreement and workflow time reduction, not improved patient outcomes.
  • Exact FDA submission
  • Checked 2026-09-04

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
Manufacturer-sponsored validation used locked, sequestered test data from one U.S. clinical site and three licensed sonographers for truthing. The reported results establish feature-level agreement and workflow time reduction, not improved patient outcomes.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Reported sensitivity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-04

Sensitivity is not promoted as a product-wide endpoint. Compare only an exact endpoint, threshold, population, version, and source if later verified.

Reported specificity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-04

Specificity is not promoted as a product-wide endpoint. Compare only an exact endpoint, threshold, population, version, and source if later verified.

Auto Plane Detection average pass rate

97 % across four cardiac views

  • EndpointAverage pass rate for agreement with sonographer-selected A4C, A3C, A2C, and SAX views; each view was required to exceed 90% agreement
  • PopulationRepresentative images from 50 U.S. patients selected from 239 patients acquired at one U.S. clinical site
  • Tested versionK241582 Auto Plane Detection on Aplio i900, i800, and i700 software V7.0

Quick Strain operation-time reduction

68 % average reduction

  • EndpointAverage reduction in operation time versus conventional three-view wall-motion tracking while meeting ICC and EDV, ESV, EF, and GLS equivalence criteria
  • PopulationRepresentative images from 50 U.S. patients selected from 239 patients acquired at one U.S. clinical site
  • Tested versionK241582 Quick Strain on Aplio i900, i800, and i700 software V7.0

Auto LVOT operation-time reduction

78 % average reduction

  • EndpointAverage reduction in operation time for three consecutive heart cycles versus manual LVOT Doppler tracing while meeting ICC and NRMSE criteria
  • PopulationRepresentative images from 45 U.S. patients selected from 239 patients acquired at one U.S. clinical site
  • Tested versionK241582 Auto LVOT on Aplio i900, i800, and i700 software V7.0

Auto AoV operation-time reduction

71 % average reduction

  • EndpointAverage reduction in operation time for three consecutive heart cycles versus manual aortic-valve Doppler tracing while meeting ICC and NRMSE criteria
  • PopulationRepresentative images from 45 U.S. patients selected from 239 patients acquired at one U.S. clinical site
  • Tested versionK241582 Auto AoV on Aplio i900, i800, and i700 software V7.0

K241582 Auto Plane Detection and Quick Strain validation

  • DesignManufacturer-sponsored retrospective feature validation using sequestered test images and three licensed sonographers for ground truth
  • Population50 selected patients with ages 20 to 98 years, balanced sex, BMI 16.4 to 71.6 kg/m2, and multiple ejection-fraction severity categories; source pool contained 239 patients from one U.S. site
  • Scopeexact submission
  • Tested versionK241582 Auto Plane Detection and Quick Strain on software V7.0
  • Samplen=50
  • Sites1
  • IndependenceSponsor or vendor study

K241582

The test data were independent of training data, but the study was manufacturer-sponsored and did not evaluate patient outcomes.

K241582 Auto LVOT and Auto AoV validation

  • DesignManufacturer-sponsored retrospective Doppler-tracing workflow validation using sequestered test images and three licensed sonographers for ground truth
  • Population45 selected patients with ages 36 to 89 years, BMI 18.8 to 71.6 kg/m2, and representative Doppler severity categories; source pool contained 239 patients from one U.S. site
  • Scopeexact submission
  • Tested versionK241582 Auto LVOT and Auto AoV on software V7.0
  • Samplen=45
  • Sites1
  • IndependenceSponsor or vendor study

K241582

Age and sex were unavailable for some anonymized cases. The study did not evaluate prospective workflow or patient outcomes.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K241582 by exact native submission identifier. This does not exclude product-family, later-version, or adverse-event information.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-04

Exact-identifier review does not prove absence of all product-family safety signals.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

Reimbursement
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging or clinical service line and verify payer, site-of-service, coding, and coverage assumptions independently.
  • Service-level, not product-specific
  • Checked 2026-09-04

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

This is not a product-specific reimbursement determination. Verify payer, site-of-service, coding, and coverage assumptions independently.

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Ultrasound images and Doppler waveforms acquired on compatible Aplio i900, i800, or i700 systems using supported linear, convex, and sector probes operating at approximately 2 to 33 MHz; the cardiac automation features use supported chamber views or LVOT and aortic-valve waveforms.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-04 · FDA 510(k) decision material K241582: Aplio i900/i800/i700 Diagnostic Ultrasound System, Software V7.0 (TUS-AI900, TUS-AI800, TUS-AI700)

  2. Routing

    Source context, not route validation: The FDA material describes the configured ultrasound console, clinical applications, supported probes and modes, and the system's measurement and review workflow.

    Scope: Exact FDA submission. This is the interface boundary described in the exact FDA decision material; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing. Prior source-backed dossier value: The system is an on-premises ultrasound platform with site-network image exchange. Canon's current interoperability page lists an IHE integration statement for Aplio i700, i800, and i900 software V6.0 or later, covering the V7.0 lineage.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-04 · FDA 510(k) decision material K241582: Aplio i900/i800/i700 Diagnostic Ultrasound System, Software V7.0 (TUS-AI900, TUS-AI800, TUS-AI700) · IHE integration statements for current Canon ultrasound products

  3. AI processing

    Source context, not route validation: The FDA material describes a mobile diagnostic ultrasound console; current room, network, archive, service, security, and enabled-option configuration remain unverified.

    Scope: Exact FDA submission. This is the release-level boundary described in the exact FDA decision material; current hosting, contracts, security, availability, upgrade path, and site configuration remain separate evidence. Prior source-backed dossier value: On-premises mobile Aplio i900, i800, or i700 ultrasound console running the K241582 software V7.0 configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-04 · FDA 510(k) decision material K241582: Aplio i900/i800/i700 Diagnostic Ultrasound System, Software V7.0 (TUS-AI900, TUS-AI800, TUS-AI700)

  4. Returned objects

    Source context, not route validation: Diagnostic ultrasound images and measurements plus feature-specific candidate cardiac-view selection, wall-motion-tracking results including EDV, ESV, EF, and GLS, and automatically traced LVOT or aortic-valve Doppler measurements for qualified-user review.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-04 · FDA 510(k) decision material K241582: Aplio i900/i800/i700 Diagnostic Ultrasound System, Software V7.0 (TUS-AI900, TUS-AI800, TUS-AI700)

  5. Viewer/worklist/report

    Unresolved route: Diagnostic ultrasound images and measurements plus feature-specific candidate cardiac-view selection, wall-motion-tracking results including EDV, ESV, EF, and GLS, and automatically traced LVOT or aortic-valve Doppler measurements for qualified-user review.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-04 · FDA 510(k) decision material K241582: Aplio i900/i800/i700 Diagnostic Ultrasound System, Software V7.0 (TUS-AI900, TUS-AI800, TUS-AI700)

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The FDA material describes a mobile diagnostic ultrasound console; current room, network, archive, service, security, and enabled-option configuration remain unverified.
  • Exact FDA submission
  • Checked 2026-09-04

This is the release-level boundary described in the exact FDA decision material; current hosting, contracts, security, availability, upgrade path, and site configuration remain separate evidence. Prior source-backed dossier value: On-premises mobile Aplio i900, i800, or i700 ultrasound console running the K241582 software V7.0 configuration.

Integration
The FDA material describes the configured ultrasound console, clinical applications, supported probes and modes, and the system's measurement and review workflow.
  • Exact FDA submission
  • Checked 2026-09-04

This is the interface boundary described in the exact FDA decision material; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing. Prior source-backed dossier value: The system is an on-premises ultrasound platform with site-network image exchange. Canon's current interoperability page lists an IHE integration statement for Aplio i700, i800, and i900 software V6.0 or later, covering the V7.0 lineage.

Security
Canon Medical's cybersecurity page states that Canon imaging systems follow a software development life cycle governed by the NIST 800-53 Risk Management Framework adhering to Defense Health Agency certification requirements; FIPS 140-2 certified cipher standards; deny-all firewall configuration and near-real-time SIEM syslog export as premium offerings; a dedicated cybersecurity risk management team for threat intelligence monitoring, advisories and incident response; and published OS and third-party update policies. Vendor statement; no certification or test report was read.
  • Vendor-wide
  • Checked 2026-10-26

Vendor statement, not an attestation. Identity bridge: the page is on us.medical.canon, Canon Medical's own site (Canon Medical Systems USA), and describes Canon Medical imaging devices generally; the FDA applicant is Canon Medical Systems Corporation, named in the corporate name-change press release on the same domain. Regional page with general device claims; exact-release scope is not established.

Training
Only Trained physicians and legally qualified healthcare professionals operating supported diagnostic ultrasound applications should operate or interpret the product; local onboarding must cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
  • Exact FDA submission
  • Checked 2026-09-04
Monitoring
Monitor K241582 by exact hardware, software, model, algorithm version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track these product-specific limits: Supported applications, probes, modes, patient populations, image quality, and exact system configuration limit use; trained professionals retain responsibility for interpretation.
  • Exact FDA submission
  • Checked 2026-09-04

Buyer-facing monitoring guidance derived from the exact cleared scope; it is not a claim that the FDA package provides a live monitoring service.

Cardiac automation package

Auto Plane Detection, Quick Strain, Auto LVOT, and Auto AoV automate candidate-view selection, wall-motion-tracking launch, and Doppler waveform tracing; the submission also adds right-ventricular and right-atrial wall-motion tracking.

exact submission · checked 2026-09-02

Confirm licensed features, supported probes and presets, user-editing behavior, and report transfer for the purchased configuration.

Supported platform

Mobile Aplio i900, i800, and i700 systems with compatible probes spanning approximately 2 to 33 MHz and standard diagnostic ultrasound imaging modes.

exact submission · checked 2026-09-02

Verify exact model, transducer, option, and software-build compatibility.

IHE integration documentation

Canon's current interoperability page lists an IHE integration statement for Aplio i700, i800, and i900 software V6.0 or later.

exact product version · checked 2026-09-02

Obtain and test the statement corresponding to the exact installed software build.

Deployment model

Mobile, on-premises diagnostic ultrasound console.

exact submission · checked 2026-09-02

Site preparation, cybersecurity controls, service access, updates, training, and downtime planning require current vendor documentation.

Release and scope verification

Map installed model, build, options, population, anatomy, inputs, outputs, and enabled functions to K241582 before acceptance.

exact submission · checked 2026-09-04

Later product-family features are not evidence that this cleared release includes them.

Deployment boundary

The FDA material describes a mobile diagnostic ultrasound console; current room, network, archive, service, security, and enabled-option configuration remain unverified.

exact submission · checked 2026-09-04

FDA-described deployment boundaries do not establish current hosting contracts, security controls, uptime, or local qualification.

Interoperability acceptance

The FDA material describes the configured ultrasound console, clinical applications, supported probes and modes, and the system's measurement and review workflow.

exact submission · checked 2026-09-04

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Supported applications, probes, modes, patient populations, image quality, and exact system configuration limit use; trained professionals retain responsibility for interpretation.

exact submission · checked 2026-09-04

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-04

No exact-product price was found in the reviewed public material; productivity or value claims require local evidence.

Lifecycle monitoring

Monitor K241582 by exact hardware, software, model, algorithm version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates.

exact submission · checked 2026-09-04

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
32Fields reviewed
11Source classes checked
20Screened PubMed leads
10Screened trial leads
0Unreviewed FDA recall leads

Screened 20 PubMed and 10 ClinicalTrials.gov records. They concern Aplio i700, i800, or i900 hardware and other ultrasound studies but do not identify the K241582 software V7.0 configuration as tested; all 30 were quarantined and none was promoted. The current discovery snapshot contains 20 PubMed and 10 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, fda decision material, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, vendor interoperability, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-04 - Exact FDA submission

    No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed

8 sources - 3 history items

Source ledger

  1. FDA 510(k) decision material K241582: Aplio i900/i800/i700 Diagnostic Ultrasound System, Software V7.0 (TUS-AI900, TUS-AI800, TUS-AI700)

    U.S. Food and Drug Administration - Published 2024-09-12 - Accessed 2026-09-04

    Scope: identity, productIdentity, purpose, clinicalUse, modality, anatomy, intendedUsers, careSetting, workflowRole, input, output, limitations, evidenceSummary

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. Medicare Coverage Database

    Centers for Medicare & Medicaid Services - Accessed 2026-09-01

    Scope: coverage, codingContext

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. IHE integration statements for current Canon ultrasound products

    Canon Medical Systems Corporation - Accessed 2026-09-02

    Scope: integration, implementationCapabilities

  8. Canon Medical: Medical Imaging Cybersecurity

    Canon Medical Systems USA - Accessed 2026-10-26

    Scope: security

Research history

  1. K241582 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K251963

LOGIQ E10s

Ge Medical Systems Ultrasound and Primary Care Diagnostics

Authorized purpose: LOGIQ E10s is a general-purpose diagnostic ultrasound system supporting the labeled adult, pediatric, cardiac, vascular, abdominal, obstetric, small-organ, musculoskeletal, urologic, and procedural applications.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-10-29
FDA-cleared K251985

LOGIQ E10

Ge Medical Systems Ultrasound and Primary Care Diagnostics

Authorized purpose: LOGIQ E10 is a general diagnostic ultrasound system for qualified users across fetal and obstetric, abdominal, gynecologic, pediatric, small-organ, breast, cardiac, vascular, musculoskeletal, urologic, transrectal, transvaginal, transesophageal, and intraoperative applications.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-10-29
FDA-cleared K250999

V8 Diagnostic Ultrasound System; cV8 Diagnostic Ultrasound System; V7 Diagnostic Ultrasound System; cV7 Diagnostic Ultrasound System; V6 Diagnostic Ultrasound System; cV6 Diagnostic Ultrasound System; V5 Diagnostic Ultrasound System; cV5 Diagnostic Ultrasound System; V4 Diagnostic Ultrasound System; cV4 Diagnostic Ultrasound System

Samsung Medison Co., Ltd.

Authorized purpose: The Samsung V-family diagnostic ultrasound systems support fetal and obstetric, abdominal, gynecologic, pediatric, small-organ, cephalic, cardiac, thoracic, vascular, musculoskeletal, urologic, transrectal, transvaginal, transesophageal, intraoperative, and dermatologic applications where labeled.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-07-18

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history